Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2019 · 10-Q
Revenue—
Net Income$4.68M$4.68MN/M vs Q2 2018 EPS Diluted$0.02$0.02N/M vs Q2 2018 Operating Cash Flowderived-$15,830,432N/M Free Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
derived
ended Jun 30, 2019 · filed Aug 9, 2019 · 40 d after period end